Leukocytes have a heparan sulfate glycocalyx that regulates recruitment during psoriasis-like skin inflammation
Science Signaling · 2025
DOI: 10.1126/scisignal.adr0011 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Signaling, 2025. Verfasst von Megan J Priestley und 12 weiteren Autor:innen. Beteiligte Einrichtung: Manchester Cell-Matrix Centre, Lydia Becker Institute of Immunology and Inflammation, Faculty of Biology, Medicine and Health, Manchester Academic He…. Hauptthemen laut MEDLINE: Heparan Sulfate, Glycocalyx, Leukocytes, Psoriasis. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 64 Literaturangaben.
Abstract (Originalsprache)
The glycocalyx is a proteoglycan-rich layer present on the surface of all mammalian cells and is particularly prevalent on endothelial cells lining the vasculature. The glycocalyx is thought to affect leukocyte migration by masking adhesion molecules and reducing leukocyte adhesion to the endothelium. Leukocyte recruitment is a key driver of inflammatory diseases, including psoriasis. Here, we found that leukocytes had the glycocalyx component heparan sulfate on their cell surface and that it was lost in response to psoriasis-like skin inflammation. In contrast, endothelial heparan sulfate was not affected. Treatment with a heparan sulfate mimetic during psoriasis-like skin inflammation in mice protected heparan sulfate from cleavage by myeloid cell–derived heparanase and resulted in reduced leukocyte accumulation in the skin. However, clinical signs of inflammation were increased because of the reduced numbers of T regulatory cells that were recruited. These findings refine our understanding of immune cell recruitment by revealing the presence and function of a heparan sulfate glycocalyx on immune cells and highlight the complex effects of heparanase inhibitors on the immune response in this context.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Manchester Cell-Matrix Centre, Lydia Becker Institute of Immunology and Inflammation, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, Manchester M13 9PT, UK.
- Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Boston, MA 02139, USA.
- Department of Chemistry and Chemical Biology, Northeastern University, Boston, MA 02115, USA.
- Ferrier Research Institute, Victoria University of Wellington, Gracefield Research Centre, Lower Hutt 5046, New Zealand.
- Laboratory for Intravital Imaging and Dynamics of Tumor Progression, VIB Center for Cancer Biology, Leuven 3000, Belgium.
- Intravital Imaging Expertise Center, VIB Center for Cancer Biology, Leuven 3000, Belgium.
ORCID-Profile: Megan J Priestley, Anna K Hains, Iashia Z Mulholland, Sam Spijkers-Shaw, Joshua C Müller, Gareth Howell, Amanda J L Ridley, H Davies-Strickleton, Rebecca L Miller, Max Nobis, Olga V Zubkova, Amy E Saunders, Douglas P Dyer
Zitieren
APA
Priestley, M. J., Hains, A. K., Mulholland, I. Z., Spijkers-Shaw, S., Müller, J. C., Howell, G., Ridley, A. J. L., Davies-Strickleton, H., Miller, R. L., Nobis, M., Zubkova, O. V., Saunders, A. E., & Dyer, D. P. (2025). Leukocytes have a heparan sulfate glycocalyx that regulates recruitment during psoriasis-like skin inflammation. Science Signaling. https://doi.org/10.1126/scisignal.adr0011
Vancouver
Priestley MJ, Hains AK, Mulholland IZ, Spijkers-Shaw S, Müller JC, Howell G, et al. Leukocytes have a heparan sulfate glycocalyx that regulates recruitment during psoriasis-like skin inflammation. Science Signaling. 2025. doi:10.1126/scisignal.adr0011
BibTeX
@article{Priestley2025,
author = {Priestley, Megan J and Hains, Anna K and Mulholland, Iashia Z and Spijkers-Shaw, Sam and Müller, Joshua C and Howell, Gareth and Ridley, Amanda J L and Davies-Strickleton, H and Miller, Rebecca L and Nobis, Max and Zubkova, Olga V and Saunders, Amy E and Dyer, Douglas P},
title = {Leukocytes have a heparan sulfate glycocalyx that regulates recruitment during psoriasis-like skin inflammation},
journal = {Science Signaling},
year = {2025},
doi = {10.1126/scisignal.adr0011}
}
EUVIMED